LONDON (Reuters) - GlaxoSmithKline has withdrawn from the race to buy Pfizer's consumer healthcare business, the British company said on Friday, endangering an auction the U.S. drugmaker hoped would bring in as much as $20 billion.

GSK pulls out of $20 billion race for Pfizer consumer assets
Read More
Bagikan Berita Ini
0 Response to "GSK pulls out of $20 billion race for Pfizer consumer assets"
Posting Komentar